Verteporfin Patent Expiration
Verteporfin is used for treating age-related macular degeneration and related conditions involving unwanted neovasculature in the eye. It was first introduced by Bausch And Lomb Ireland Ltd
Verteporfin Patents
Given below is the list of patents protecting Verteporfin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Visudyne | US5756541 | Vision through photodynamic therapy of the eye |
Mar 11, 2016
(Expired) | Bausch Lomb Ireland |
| Visudyne | US5798349 | Use of green porphyrins to treat neovasculature in the eye |
Aug 25, 2015
(Expired) | Bausch Lomb Ireland |
| Visudyne | US5707608 | Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer |
Aug 02, 2015
(Expired) | Bausch Lomb Ireland |
| Visudyne | US5770619 | Method of activating photosensitive agents |
Jan 06, 2015
(Expired) | Bausch Lomb Ireland |
Verteporfin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List